Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry
Tirzepatide is approved by the FDA for ongoing, long-term use in managing type 2 diabetes and has been found safe and effective for sustained weight management under medical supervision
But as their popularity has grown, so has a common concern among patients: Why are GLP-1 medications so expensive in the U.S
2024 FDA Developments Several important FAA and FDA actions occurred in 2024: In January 2024, tirzepatide (Zepbound, Mounjanaro) was added to the FAAs Conditionally Acceptable Weight Loss Medications category, but medical certification required Special Issuance
Quality of life enhancements, including improved mobility, self-confidence, and ability to participate in desired activities, constitute important treatment outcomes